New concepts of immune modulation in xenotransplantation

Transplantation

Volumn 96, Issue 11, 2013, Pages 937-945

  Satyananda, Vikas ^a   Hara, Hidetaka ^a   Ezzelarab, Mohamed B ^a   Phelps, Carol ^b   Ayares, David ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b REVIVICOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELATACEPT; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; GENE DELETION; GENETIC MANIPULATION; GRAFT FAILURE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MESENCHYMAL STROMA CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SWINE; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; XENOTRANSPLANTATION;

ADAPTIVE IMMUNITY; ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENETIC THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; PRIMATES; SWINE; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 84889882118     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829bbcb2     Document Type: Review

References (99)

1. Cooper DKC, Lanza RP. XenoVThe Promise of Transplanting Animal Organs into Humans. New York: Oxford University Press; 2000: 1Y274.
2. Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantationVthe next medical revolution Lancet 2012; 379: 672.
3. Van der Windt DJ, Bottino R, Kumar G, et al. Clinical islet xenotransplantationVhow close are we Diabetes 2012; 61: 3046.
4. Lexer G, Cooper DKC, Rose AG, et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 1986; 5: 411.
5. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
6. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in >1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805.
7. Sachs DH, Sykes M, Robson SC, et al. Xenotransplantation. Adv Immunol 2001; 79: 129.
8. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249.
9. Buhler LH, Cooper DKC. How strong is the T cell response in the pigto-primate model Xenotransplantation 2005; 12: 85.
10. Lin YJ, Hara H, Tai HC, et al. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 2008; 86: 1452.
11. Dorling A, Lombardi G, Binns R, et al. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996; 26: 1378.
12. Brouard S, Gagne K, Blancho G, et al. T cell response in xenorecognition and xenografts: A review. Hum Immunol 1999; 60: 455.
13. Davila E, Byrne GW, LaBreche PT, et al. T-cell responses during pigto-primate xenotransplantation. Xenotransplantation 2006; 13: 31.
14. Muller YD, Ehirchiou D, Golshayan D, et al. Potential of T-regulatory cells to protect xenografts. Curr Opin Organ Transplant 2012; 17: 155.
15. Bravery CA, Batten P, Yacoub MH, et al. Direct recognition of SLAand HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation 1995; 60: 1024.
16. Faustman DL, Steinman RM, Gebel HM, et al. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A 1984; 81: 3864.
17. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
18. Mirzaie M, Meyer T, Berger D, et al. Expression of porcine major histocompatibility antigens in cardiac tissue. APMIS 1998; 106: 935.
19. Houser SL, Benjamin LC, Wain JC, et al. Constitutive expression of major histocompatibility complex class II antigens in pulmonary epithelium and endothelium varies among different species. Transplantation 2004; 77: 605.
20. Murray AG, Khodadoust MM, Pober JS, et al. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
21. Rogers NJ, Jackson IM, Jordan WJ, et al. Cross-species costimulation: Relative contributions of CD80, CD86, and CD40. Transplantation 2003; 75: 2068.
22. Koshika T, Phelps C, Fang J, et al. Relative efficiency of porcine and human CTLA4-Ig in inhibiting human CD4+ T cell responses costimulated by porcine and human B7 molecules. Immunology 2011; 134: 386.
23. Corcoran PC, Horvath KA, Singh AK, et al. Surgical and nonsurgical complications of a pig to baboon heterotopic heart transplantation model. Transplant Proc 2010; 42: 2149.
24. Dorling A, Lechler RI. T cell-mediated xenograft rejection: Specific tolerance is probably required for long term xenograft survival. Xenotransplantation 1998; 5: 234.
25. Scalea J, Hanecamp I, Robson SC, et al. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 2012; 19: 23.
26. Buhler L, Basker M, Alwayn IP, et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70: 1323.
27. Houser SL, Kuwaki K, Knosalla C, et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11: 416.
28. Kuwaki K, Knosalla C, Dor FJ, et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-CD154 monoclonal antibody-based regimen. Am J Transplant 2004; 4: 363.
29. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1, 3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005; 11: 29.
30. Lin CC, Chen D, McVey JH, et al. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 2008; 86: 702.
31. Robson SC, Cooper DKC, d'Apice AJF. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166.
32. Cowan PJ, Robson SC, d'Apice AJF. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 2011; 16: 214.
33. Ezzelarab C, Ayares D, Cooper DKC, et al. Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells. Xenotransplantation 2012; 19: 311.
34. Esmon CT. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006; 32: 49.
35. Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011; 9: 182.
36. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13: 34.
37. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
38. Cooper DKC, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342: 682.
39. Phelps CJ, Koike C, Vaught TD, et al. Production of >1,3- galactosyltransferase-deficient pigs. Science 2003; 299: 411.
40. Kolber-Simonds D, Lai L, Watt SR, et al. Production of >1,3-galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 19: 7335.
41. Galili U, Shohet SB, Kobrin E, et al. Man, apes, and Old World monkeys differ from other mammals in the expression of alphagalactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
42. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in man. Transplant Proc 1992; 24: 559.
43. Tseng Y-L, Kuwaki K, Dor FJ, et al. >1,3-Galactosyltransferase geneknockout pig heart transplantation in baboons with survival approaching six months. Transplantation 2005; 80: 1493.
44. Azimzadeh AM, Kelishadi S, Ezzelarab M, et al. Early graft failure of GTKO pig organs in baboons is reduced by hCPRP expression. Am J Transplant 2010; 10: 186 (abstract 499).
45. McGregor CGA, Ricci D, Miyagi N, et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012; 93: 686.
46. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999; 67: 18.
47. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered >-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58: 330.
48. McGregor CGA, Davies WR, Oi K, et al. Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005; 130: 844.
49. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
50. Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
51. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005; 23: 821.
52. Locke JE, Magra CM, Singer DL, et al. The use of antibody to complement protein C3 for salvage of severe antibody-mediated rejection. Am J Transplant 2009; 9: 231.
53. Dawson KL, Parulekar A, Seethamraju H. Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant 2012; 31: 1325.
54. Wilhite T, Ezzelarab C, Hara H, et al. The effect of Gal expression on pig cells on the human T-cell xenoresponses. Xenotransplantation 2012; 19: 56.
55. Ezzelarab M, Ezzelarab C, Wilhite T, et al. Genetically-modified pig mesenchymal stromal cells: Xenoantigenicity and effect on human Tcell xenoresponses. Xenotransplantation 2011; 18: 183.
56. Schubert T, Poilvache H, Galli C, et al. Galactosyl-knockout engineered pig as a xenogenic donor source of adipose MSCs for bone regeneration. Biomaterials 2013; 34: 3279.
57. Phelps C, Ball S, Vaught T, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009; 16: 477.
58. Phelps C, Vaught T, Ball S, et al. Multi-transgenic pigs designed for xenoislet transplants. Xenotransplantation 2009; 16: 374 (abstract IXA-O-7.3).
59. Ayares D, Vaught T, Ball S, et al. Islet-specific expression of TFPI, CD39, and CTLA4Ig in transgenic pigs designed for xenoislet transplantation. Xenotransplantation 2011; 18: 269 (abstract 119).
60. Ayares D, Phelps C, Vaught T, et al. Multi-transgenic pigs for vascularized pig organ xenografts. Xenotransplantation 2011; 18: 269 (abstract 120).
61. Ayares D. Multi-transgenic pigs for xenotransplantation. Reprod Fertil Dev 2012; 25: 320. doi.10.1071/RDv25n1Ab344.
62. Martin C, Plat M, Nerriére-Daguin V, et al. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res 2005; 14: 373.
63. Lévêque X, Cozzi E, Naveilhan P, et al. Intracerebral xenotransplantation: Recent findings and perspectives for local immunosuppression. Curr Opin Organ Transplant 2011; 16: 190.
64. Yun S, Gustafsson K, Fabre JW. Suppression of human anti-porcine Tcell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Transplantation 1998; 66: 103.
65. Hara H, Crossley T, Witt W, et al. Dominant-negative CIITA transgenic pigsVeffect on the human anti-pig T cell immune response and immune status. Am J Transplant 2010; 10: 187. (abstract 503).
66. Hara H, Witt W, Crossley T, et al. Human dominant-negative class II transactivator transgenic pigsVeffect on the human anti-pig T cell immune response and immune status. Immunology 2013; 140: 39.
67. Seebach JD, Comrack C, Germana S, et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3655.
68. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000; 30: 586.
69. Crew MD. Play it in E or G: utilization of HLA-E and-G in xenotransplantation. Xenotransplantation 2007; 14: 198.
70. Weiss EH, Lilienfeld BG, Muller S, et al. HLA-E/human beta2-microglobulin transgenic pigs: Protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009; 87: 35.
71. Sasaki H, Xu XC, Mohankumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and independent pathways. J Immunol 1999; 163: 6301.
72. Matsunami K, Miyagawa S, Nakai R, Yamada M, et al. Modulation of the leader peptide sequence of the HLA-E gene up regulates its expression and down regulates natural killer cell mediated swine endothelial cell lysis. Transplantation 2002; 73: 1582.
73. Lin CC, Ezzelarab M, Shapiro R, et al. Tissue factor expression on recipient platelets is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010; 10: 1556.
74. Klymiuk N, Aigner B, Brem G, et al. Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev 2010; 77: 209.
75. Petersen B, Ramackers W, Lucas-Hahn A, et al. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation 2011; 18: 355.
76. Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009; 16: 522.
77. Schwinzer R, BaarsW, Borns K, et al. Over-expression of human HO-1 and A20 in porcine cells: Effects on susceptibility to cell-mediated lysis and inflammatory cytokines. Xenotransplantation 2011; 18: 269 (abstract 122).
78. Li Q, Deng SB, Xia S, et al. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: A clinical study. Med Clin (Barc) 2013; 140: 532.
79. Ezzelarab M, Welchons D, Torres C, et al. Atorvastatin downregulates the primate cellular response to porcine aortic endothelial cells in vitro. Transplantation 2008; 86: 733.
80. Olofsson PS, Rosas-Ballina M, Levine YA, et al. Rethinking inflammation: Neural circuits in the regulation of immunity. Immunol Rev 2012; 248: 188.
81. Ekser B, Burlak C, Waldman JP, et al. Immunobiology of liver xenotransplantation. Expert Rev Clin Immunol 2012; 8: 621.
82. Pierson RN 3rd, Dorling A, Ayares D, et al. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009; 16: 263.
83. Lambrigts D, Sachs DH, Cooper DKC. Discordant organ xenotransplantation in primatesVworld experience and current status. Transplantation 1998; 66: 547.
84. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296.
85. Ekser B, Kumar G, Cooper DKC. Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates. Curr Opin Organ Transplant 2011; 16: 222.
86. Zhu X, Dor FJMF, Cooper DKC. Pig-to-nonhuman primate heart transplantation: Immunologic progress over 20 years. J Heart Lung Transplant 2007; 26: 210.
87. Mohiuddin MM, Corcoran PC, Singh AK, et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 2012; 12: 763.
88. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3- galactosyltransferase gene knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32.
89. Griesemer AD, Hirakata A, Shimizu A, et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009; 9: 2669.
90. Knosalla C, Yazawa K, Behdad A, et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant 2009; 9: 1006.
91. Porter CM, Horvath-Arcidiacono JA, Singh AK, et al. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model. Xenotransplantation 2007; 14: 298.
92. O'Connell PJ, Yi S, Carrington EM, et al. Role of regulatory T cells in xenotransplantation. Curr Opin Organ Transplant 2010; 15: 224.
93. Kumar G, Hara H, Long C, et al. Adipose-derived mesenchymal stem cells from genetically-modified pigs immunogenicity and immune modulatory properties. Cytotherapy 2012; 14: 494.
94. Li J, Ezzelarab MB, Cooper DKC. Do mesenchymal stem cells function across species barriers Relevance for xenotransplantation. Xenotransplantation 2012; 19: 273.
95. Muller YD, Seebach JD, Buhler LH, et al. Transplantation tolerance: Clinical potential of T regulatory cells. Self Nonself 2011; 2: 26.
96. Muller YD, Mai G, Morel P, et al. Anti-CD 154 mAb and rapamycin induce T-regulatory cell mediated tolerance in the rat to mouse islettransplantation. PLoS One 2010; 5: E10352.
97. Ding Q, Lu L, Zhou X, et al. Human PD-L1 overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells. J Leukoc Biol 2011; 90: 77.
98. Plege A, Borns K, Baars W, et al. Suppression of human T-cell activation and expansion of regulatory T-cells by pig cells overexpressing PD ligands. Transplantation 2009; 87: 975.
99. Tseng Y-L, Sachs DH, Cooper DKC. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: A review of progress. Transplantation 2005; 79